Please login to the form below

Letermovir

This page shows the latest Letermovir news and features for those working in and with pharma, biotech and healthcare.

EC grants MSD’s Prevymis orphan product designation

The status for Prevymis’ (letermovir) covers the prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). ... to help ensure that appropriate patients

Latest news

CHMP backs MSD’s CMV infection treatment

Merck Sharp &Dohme (MSD) is closing on European approval for its infection treatment Prevymis (letermovir) after it received backing from the Committee for Medicinal Products for Human Use’s (CHMP) last ... The US Food and Drug Administration approved
Merck says drug for CMV in transplant patients hits targets

Letermovir on course for fast-track 2017 filing and head start in prospective $350m market. ... Letermovir has been granted orphan drug status in the EU and the US, and has also been earmarked for fast-track review by the FDA.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Pharma deals during October 2012

CMV) and related assets. Letermovir has orphan drug status in the EU and the US, where it has also been granted fast track designation. ... 587. AiCuris / Merck &Co. Licence. Letermovir (phase IIb) and antiviral portfolio for CMV.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager- Healthcare Advertising: Negotiable

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Principal Health Economist - North-West: Negotiable

Account Executive/ Senior Account Executive: competitive Salary Offfered

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager / Account Director: Competative

Experienced Medical Writers: Competitive Salary and Benefits

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Business Development Director – Health Education: excellent commission

Systematic Reviewer - Oxford: Negotiable

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Account Manager- Healthcare Advertising: Negotiable

Senior Account Manager: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Editorial Manager - MedComms: DOE

Medical (Scientific) Director: £120, 000 benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Manager: Negotiable

Business Director: Competitive Salary Offered

Healthcare Communications Account Directors x 2: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today: Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...